What are the benefits of early invasive management strategies in high-risk patients with non-ST-segment elevation acute coronary syndromes?
A study published in the JAMA journal in 2004 found that utilizing early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) resulted in a lower incidence of death, myocardial infarction, and recurrent angina at 30 days when compared to a conservative strategy. The study also found that the early invasive strategy was associated with significantly fewer major bleeding events and lower costs.